Skip to main content

Table 4 Comparison of the changes of parameters before and after treatment between two groups

From: Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients

 

Sevelamer

(n = 23)

Calcium Carbonate

(n = 27)

P

Δ Ca (mg/dL)

0.26 ± 0.55

0.80 ± 0.93

0.015*

Δ P (mg/dL)

−1.47 ± 0.98

−1.53 ± 1.27

0.871

Δ iPTH (pg/mL)

12.10 (216.60)

−137.10 (255.70)

0.026*

Δ ALK-P (IU/L)

30.26 ± 45.78

−2.26 ± 22.69

0.004*

Δ HsCRP (mg/L)

−0.9 (2.7)

0.1 (3.8)

0.025*

Δ Hct (%)

−0.30 ± 4.00

−0.00 ± 3.39

0.785

Δ Albumin (g/L)

0.00 ± 2.72

0.82 ± 2.31

0.241

Δ TG (mg/dL)

−11.00 (70)

−13.00 (93)

0.346

Δ LDL-C (mg/dL)

−45.04 ± 28.31

−7.74 ± 27.59

0.000*

Δ Fetuin-A (ug/mL)

−49.44 (113.78)

−38.21 (78.51)

0.345

  1. Δ Ca: the change in serum calcium concentration
  2. Data are mean ± standard deviation or median (interquartile range, IQR)
  3. P < 0.05*